NIAID supports the study of global research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases and conditions. In addition to advancing these scientific goals, NIAID global research helps to improve the health of millions of people around the world, to protect the United States against infectious disease threats, and to promote international economic and political stability. Together, these efforts establish NIAID as a leader in global health.
NIH Launches Largest Clinical Trial Focused on HIV-Related Cardiovascular Disease—April 15, 2015
NIH, South African Medical Research Council Award $8 Million in HIV, TB Grants—April 13, 2015
Ebola Test Vaccines Appear Safe in Phase 2 Liberian Clinical Trial—March 26, 2015
NIH Study Finds No Evidence of Accelerated Ebola Virus Evolution in West Africa—March 26, 2015
All Global Research News Releases
News From NIAID-Supported Institutions
Last Updated April 15, 2015